Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: A role for kupffer cells?

Journal of Carcinogenesis

Volumn 5, Issue , 2006, Pages

  Alsarra, Ibrahim A ^a   Brockmann, William G ^a   Cunningham, Michael L ^b   Badr, Mostafa Z ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; INTERLEUKIN 1BETA; PALMITIC ACID METHYL ESTER; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER CANCER; LIVER CARCINOGENESIS; LIVER HYPERPLASIA; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RAT; SEROLOGY;

EID: 33845637290     PISSN: None     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-5-26     Document Type: Article

References (26)

1. Reddy JK: Carcinogenecity of peroxisome proliferators: evaluation and mechanisms. Biochem Soc Trans 1999, 18:92-94.
2. Marsman DS, Cattley RC, Conway JG, Popp JA: Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl) phthalate and [4-Chloro-6-(2,3-xylidino))-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res 1988, 48:6739-6744.
3. Soliman M, Cunningham M, Morrow J, Roberts LJ, Badr M: Evidence against peroxisome proliferation-induced hepatic oxidative damage. Levels of esterified isoprostanes in livers of mice fed a diet containing [4-chloro-6-(2,3-xylidino)-2pyrimidinylthio]acetic acid (Wy-14,643). Biochem Pharmacol 1997, 53:1369-1374.
4. Rose M, Germolec DR, Schoonhoven R, Thurman RG: Kupffer cells are casually responsible for mitogenic effect of peroxisome proliferators. Carcinogenesis 1997, 18:1453-1456.
5. Bojes HK, Germolec DR, Simeonova P, Bruccoleri A, Schoonhiven R, Luster MI, Thurman RG: Antibodies to tumor necrosis factor α prevent increases in cell replication in liver due to the potent peroxisome proliferator, Wy-14,643. Carcinogenesis 1997, 18:669-674.
6. Karam WG, Ghanayem BI: Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell cocultures. Carcinogenesis 1997, 18:2077-2083.
7. Rolfe M, James N, Roberts R: Tumor necrosis factor α (TNFα) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis 1997, 18:2277-2280.
8. Youssef J, Badr M: Activated Kupper cells attenuate the liver response to the peroxisome proliferator perfluorooctanoic acid. Mol Cell Biochem 1997, 169:143-147.
9. Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, Hawata H: Activation of retinoic X receptor and peroxisome proliferator-activated receptor-γ inhibits nitric oxide and tumor necrosis factor-α production in rat Kupffer cells. Hepatology 2001, 33:91-99.
10. Peters J, Rusyn I, Rose M, Gonzalez F, Thurman RG: Peroxisome proliferator-activated receptor α is restricted to hepatic parenchymal cells, not kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis 2000, 21:823-826.
11. Gilver B, Alberts D, Wollenberg G, Pitzenberger M, DeLuca J, Lawrence J: TNFα is not required for Wy-14,643-induced proliferation in mice. Toxicologist 2000, 54:A1975.
12. Lawrence J, Wollenberg G, DeLuca J: Tumor necrosis factor alpha is not required for Wy-14,643-induced cell proliferation. Carcinogenesis 2001, 22:381-386.
13. Rizzardini M, Zappone M, Villa P, Gnocchi P, Sironi M, Diomede L, Meazza C, Monshouwer M, Cantoni L: Kupffer cell depletion partially prevents hepatic heme oxygenase I messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1β. Hepatology 1998, 27:703-710.
14. Badr MZ: Induction of peroxisomal enzyme activities by di-(2-ethylhexyl) phathalate in thyroidectomized rats with parathyroid transplants. J Pharmacol Exp Ther 1992, 263:1105-1110.
15. Lazarow PB, Deduve C: A fatty acyl-CoA oxidizing system in rat liver peroxisomes: enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 1997, 73:2043-2046.
16. Cunningham ML, Fley J, Maronpot RR, Mattews HB: Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair-2,6-and 2,4-diaminotoluene. Toxicol Appl Pharmacol 1991, 107:562-567.
17. Cunningham ML, Maronpot RR, Thompson M, Bucher JR: Early responses of the liver of B6C3fI mice to the hepatocarcinogen oxazepam. Toxicol Appl Pharmaco 1994, 124:31-38.
18. Kraupp-Grasl B, Huber W, Taper H, Schulte-Hermann R: Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res 1991, 51:666-671.
19. Klaunig J, Babich M, Baetcke K, Cook J, Corton C, David R, DeLuca J, Lai D, McKee R, Peters J, Roberts R, Fenner-Crisp P: PPARα agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol 2003, 33:655-780.
20. Holden P, Hasmall S, James N, West D, Brindle R, Gonzalez F, Peters J, Roberts R: Tumor necrosis factor α (TNFα): role in suppression of apoptosis by the peroxisome proliferator nafenopin. Cell Mol Biol 2000, 46:29-39.
21. Rose M, Rusyn I, Bojes H, Germolec D, Luster M, Thurman RG: Role of kupffer cells in peroxisome proliferator-induced hepatocyte proliferation. Drug Metab Rev 1999, 31:87-116.
22. Rusyn I, Tsukamoto H, Thurman RG: Wy-14,643 rapidly activates nuclear factor κB in Kupffer cells. Carcinogenesis 1998, 19:1217-1222.
23. Rusyn I, Yamashina Y, Segal B, Schoonhoven R, Hollard S, Cattley R, Swenberg J, Thurman RG: Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Res 2000, 60:4798-4803.
24. Maloney E, Waxman D: trans-Activation of PPARα and PPARγ by structurally diverse environmental chamicals. Toxicol Appl Pharmacol 1999, 161:209-218.
25. Thottassery J, Winberg L, Youssef J, Cunningham ML, Badr M: Regulation of perfluorooctanoic acid-induced peroxisomal enzyme activities and hepatocellular growth by adrenal hormones. Hepatology 1992, 15:316-322.
26. Cunningham ML, Soliman M, Badr M, Matthews H: Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver. Cancer Lett 1995, 95:93-97.